Psychoactive Drugs Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Psychoactive Drugs stocks.

Psychoactive Drugs Stocks Recent News

Date Stock Title
Jul 11 AZN The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian
Jul 11 AZN Three UK Exchange Stocks Estimated To Be Valued Up To 39.2% Below Intrinsic Worth
Jul 10 AZN Top Stock Reports for Novo Nordisk, AbbVie & AstraZeneca
Jul 10 ZVRA Zevra (ZVRA) Rises on Update on Niemann-Pick Disease Type C Drug
Jul 10 ZVRA Zevra Therapeutics (ZVRA) Surges 21.9%: Is This an Indication of Further Gains?
Jul 10 ZVRA AbbVie names new R&D head; Arcutis eczema cream approved
Jul 9 ZVRA FDA Convenes Expert Panel Meeting For Zevra Therapeutics' Arimoclomol, Analyst Optimistic About Approval Despite Small Patient Base
Jul 9 ZVRA Zevra announces FDA meeting to review its Niemann-Pick disease type C treatment drug
Jul 9 LEXX Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study
Jul 9 ZVRA Zevra Announces FDA Advisory Committee Meeting to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C
Jul 9 AZN AstraZeneca PLC (AZN): Is This FTSE Dividend Stock a Good Buy Right Now?
Jul 8 LEXX Lexaria Receives New Patents For Antiviral Drug Delivery and for Treating Epilepsy
Jul 8 AZN The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Jul 6 SNDL SNDL to acquire cannabis edibles maker Indiva
Jul 6 SNDL SNDL Acquires Delta 9 Cannabis' Debt, Ascends to Senior Secured Creditor Status
Jul 5 SNDL SNDL Enters into a Stalking Horse Purchase Agreement for Indiva Limited's Business and Assets
Jul 5 AZN AstraZeneca & Aptamer partner to bolster targeted siRNA therapies
Jul 5 AZN AstraZeneca’s Tagrisso plus chemotherapy wins EU approval for NSCLC
Jul 5 AZN AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
Jul 5 AZN Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Psychoactive Drugs

A psychoactive drug, psychopharmaceutical, or psychotropic is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition, or behavior. These substances may be used medically; recreationally; to purposefully improve performance or alter one's consciousness; as entheogens; for ritual, spiritual, or shamanic purposes; or for research. Some categories of psychoactive drugs, which have therapeutic value, are prescribed by physicians and other healthcare practitioners. Examples include anesthetics, analgesics, anticonvulsant and antiparkinsonian drugs as well as medications used to treat neuropsychiatric disorders, such as antidepressants, anxiolytics, antipsychotics, and stimulant medications. Some psychoactive substances may be used in the detoxification and rehabilitation programs for persons dependent on or addicted to other psychoactive drugs.
Psychoactive substances often bring about subjective (although these may be objectively observed) changes in consciousness and mood that the user may find rewarding and pleasant (e.g., euphoria or a sense of relaxation) or advantageous (e.g. increased alertness) and are thus reinforcing. Substances which are both rewarding and positively reinforcing have the potential to induce a state of addiction – compulsive drug use despite negative consequences. In addition, sustained use of some substances may produce physical or psychological dependence or both, associated with somatic or psychological-emotional withdrawal states respectively. Drug rehabilitation attempts to reduce addiction, through a combination of psychotherapy, support groups, and other psychoactive substances. Conversely, certain psychoactive drugs may be so unpleasant that the person will never use the substance again. This is especially true of certain deliriants (e.g. Jimson weed), powerful dissociatives (e.g. Salvia divinorum), and classic psychedelics (e.g. LSD, psilocybin), in the form of a "bad trip".
Psychoactive drug misuse, dependence and addiction have resulted in legal measures and moral debate. Governmental controls on manufacture, supply and prescription attempt to reduce problematic medical drug use. Ethical concerns have also been raised about over-use of these drugs clinically, and about their marketing by manufacturers. Popular campaigns to allow certain recreational drug use (e.g. cannabis) are also ongoing.

Browse All Tags